MDCE to Cancel 680 Million CEO Shares and Slash 980 Million Authorized Shares as Stock Trades Near 52-Week Low; Q2 Rebound Underway
Medical Care Technologies (OTC:MDCE) has announced a major share structure reduction plan amid trading near 52-week lows. The company will cancel 680 million CEO-owned common shares and reduce authorized shares by 980 million, bringing the total authorized share count from 7.98 billion to 7 billion.
The restructuring will decrease outstanding shares from 2.69 billion to 2.01 billion, while the float remains unchanged at 959.57 million shares. The CEO will maintain control through 1 preferred share convertible into 3 billion common shares. The company also reported a stronger-than-expected Q2 rebound and highlighted growth initiatives through its subsidiaries Infinite Auctions and Real Game Used, featuring high-profile sports memorabilia auctions.
Medical Care Technologies (OTC:MDCE) ha annunciato un importante piano di riduzione della struttura azionaria, in un momento in cui il titolo si avvicina ai minimi delle ultime 52 settimane. La società cancellerà 680 milioni di azioni ordinarie di proprietà del CEO e ridurrà le azioni autorizzate di 980 milioni, portando il totale delle azioni autorizzate da 7,98 miliardi a 7 miliardi.
La ristrutturazione ridurrà le azioni in circolazione da 2,69 miliardi a 2,01 miliardi, mentre il flottante rimarrà invariato a 959,57 milioni di azioni. Il CEO manterrà il controllo tramite 1 azione privilegiata convertibile in 3 miliardi di azioni ordinarie. La società ha inoltre riportato una ripresa del secondo trimestre superiore alle aspettative e ha evidenziato iniziative di crescita attraverso le sue controllate Infinite Auctions e Real Game Used, che organizzano aste di memorabilia sportivi di alto profilo.
Medical Care Technologies (OTC:MDCE) ha anunciado un importante plan de reducción de la estructura accionaria en medio de cotizaciones cercanas a mínimos de 52 semanas. La compañía cancelará 680 millones de acciones comunes propiedad del CEO y reducirá las acciones autorizadas en 980 millones, disminuyendo el total de acciones autorizadas de 7.98 mil millones a 7 mil millones.
La reestructuración reducirá las acciones en circulación de 2.69 mil millones a 2.01 mil millones, mientras que el flotante se mantiene sin cambios en 959.57 millones de acciones. El CEO mantendrá el control mediante 1 acción preferente convertible en 3 mil millones de acciones comunes. La compañía también reportó una recuperación del segundo trimestre mejor de lo esperado y destacó iniciativas de crecimiento a través de sus subsidiarias Infinite Auctions y Real Game Used, que realizan subastas de recuerdos deportivos de alto perfil.
Medical Care Technologies (OTC:MDCE)는 52주 최저가 근처에서 주식 구조 대폭 축소 계획을 발표했습니다. 회사는 CEO 소유의 보통주 6억 8천만 주를 취소하고 발행 가능한 주식을 9억 8천만 주 줄여 총 발행 가능한 주식을 79억 8천만 주에서 70억 주로 줄일 예정입니다.
이번 구조 조정으로 유통 주식 수는 26억 9천만 주에서 20억 1천만 주로 감소하지만 유통 주식 수는 9억 5천 9백 57만 주로 변동이 없습니다. CEO는 3억 주의 보통주로 전환 가능한 1주의 우선주를 통해 지배권을 유지할 예정입니다. 회사는 또한 예상보다 강한 2분기 반등 실적을 보고했으며, 자회사인 Infinite Auctions와 Real Game Used를 통한 고급 스포츠 기념품 경매 성장 계획을 강조했습니다.
Medical Care Technologies (OTC:MDCE) a annoncé un plan majeur de réduction de la structure actionnariale alors que le titre se négocie près de ses plus bas sur 52 semaines. La société va annuler 680 millions d’actions ordinaires détenues par le CEO et réduire les actions autorisées de 980 millions, ramenant le nombre total d’actions autorisées de 7,98 milliards à 7 milliards.
La restructuration fera passer les actions en circulation de 2,69 milliards à 2,01 milliards, tandis que le flottant reste inchangé à 959,57 millions d’actions. Le CEO conservera le contrôle via 1 action privilégiée convertible en 3 milliards d’actions ordinaires. La société a également rapporté un rebond du deuxième trimestre plus fort que prévu et a mis en avant des initiatives de croissance à travers ses filiales Infinite Auctions et Real Game Used, spécialisées dans les ventes aux enchères de souvenirs sportifs de prestige.
Medical Care Technologies (OTC:MDCE) hat einen bedeutenden Plan zur Reduzierung der Aktienstruktur angekündigt, während die Aktie nahe einem 52-Wochen-Tief handelt. Das Unternehmen wird 680 Millionen vom CEO gehaltene Stammaktien stornieren und die genehmigten Aktien um 980 Millionen reduzieren, wodurch die Gesamtzahl der genehmigten Aktien von 7,98 Milliarden auf 7 Milliarden sinkt.
Die Umstrukturierung wird die ausstehenden Aktien von 2,69 Milliarden auf 2,01 Milliarden verringern, während der Streubesitz unverändert bei 959,57 Millionen Aktien bleibt. Der CEO behält die Kontrolle durch 1 Vorzugsaktie, die in 3 Milliarden Stammaktien wandelbar ist. Das Unternehmen meldete außerdem eine stärker als erwartete Erholung im zweiten Quartal und hob Wachstumsinitiativen durch seine Tochtergesellschaften Infinite Auctions und Real Game Used hervor, die hochkarätige Sportmemorabilien-Auktionen veranstalten.
- None.
- Stock trading near 52-week low indicates weak market performance
- CEO maintains significant potential dilution through preferred share convertible into 3 billion common shares
- Large authorized share count of 7 billion remains despite reduction
Massive 1.66 Billion Share Reduction Signals Long-Term Commitment to Shareholder Value as Company Prepares to Report Q2 Rebound Performance
MESA, ARIZONA / ACCESS Newswire / July 2, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE ) today announced an aggressive two-part share structure reduction plan aimed at restoring shareholder confidence and positioning the company for long-term growth. The announcement comes as MDCE trades near its 52-week low, while management confirms that Q2 closed with a stronger-than-expected rebound , to be detailed in the upcoming quarterly report.
As part of the restructuring, the Company will:
Cancel 680,000,000 common shares held by its Chief Executive Officer, and
Reduce its authorized share count by 980,000,000 shares - cutting the limit from 7.98 billion to 7.0 billion.
Both actions will be processed through MDCE's transfer agent and are expected to be completed within 7 to 10 business days .
Share Structure Snapshot (Before & After):
Category | Before | After (Projected) |
|---|---|---|
Authorized Shares (A/S) | 7,979,999,990 | 7,000,000,000 |
Outstanding Shares (O/S) | 2,692,075,220 | 2,012,075,220 |
CEO-Owned Common Shares | 680,000,000 | 0 |
Float (Est.) | 959,575,220 | 959,575,220 (unchanged) |
"With this move, MDCE is sending a clear message: we're serious about restructuring, regaining investor trust, and delivering long-term value," said an MDCE spokesperson. "As we prepare to report our Q2 rebound, these changes create the foundation for our next phase of growth."
The CEO will retain 1 preferred share convertible into 3 billion common shares , ensuring leadership continuity and voting control while eliminating dilution concerns tied to insider common holdings.
Key Growth Drivers:
GOAT Collection Auction (Live Now) - Featuring game-worn memorabilia from Michael Jordan, LeBron James and Kobe Bryant
The Grail Collection Auction (Following Right After) - A high-value, higher volume investment-grade showcase of iconic sports memorabilia expected to set new auction benchmarks
Together, these launches position MDCE's operating subsidiaries - Infinite Auctions and Real Game Used - at the forefront of the high-growth collectible investment sector.
About Medical Care Technologies Inc. (OTC Pink: MDCE)
MDCE is the parent company of Infinite Auctions and Real Game Used , platforms focused on the acquisition, authentication, and sale of premium game-used memorabilia and investment-grade collectible assets.
Contact Information
Infinite Auctions
Media & Investor Relations
Email: info@infiniteauctions.com
Website: www.infiniteauctions.com / www.mdcestock.com / www.realgameused.com
Mesa, AZ
Safe Harbor Statement
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding future performance, expected results, growth strategies, operational plans, and market opportunities. These forward-looking statements are based on current beliefs and assumptions of management and involve known and unknown risks, uncertainties, and other factors which may cause actual results, performance, or achievements of Medical Care Technologies Inc. (OTC Pink: MDCE) and its subsidiaries to differ materially from those expressed or implied in such statements.
Factors that may affect actual results include, but are not limited to, the success of planned share cancellations, market acceptance of company initiatives, fluctuations in the collectibles market, and general economic conditions. Readers are cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law.
SOURCE: Medical Care Technologies Inc. (OTC Pink:MDCE)
View the original press release on ACCESS Newswire
FAQ
What changes did MDCE announce to its share structure in July 2025?
How will MDCE's share cancellation affect the company's outstanding shares?
What voting control will MDCE's CEO maintain after the share cancellation?
What growth initiatives did MDCE announce alongside the share restructuring?
When will MDCE complete its share structure changes?
